| Title : Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study) - Furusawa_2023_Diabetes.Obes.Metab__ |
| Author(s) : Furusawa S , Nomoto H , Yokoyama H , Suzuki Y , Tsuzuki A , Takahashi K , Miya A , Kameda H , Cho KY , Takeuchi J , Nagai S , Taneda S , Kurihara Y , Nakamura A , Atsumi T |
| Ref : Diabetes Obes Metab , : , 2023 |
| Abstract : Furusawa_2023_Diabetes.Obes.Metab__ |
| ESTHER : Furusawa_2023_Diabetes.Obes.Metab__ |
| PubMedSearch : Furusawa_2023_Diabetes.Obes.Metab__ |
| PubMedID: 38073422 |
Furusawa S, Nomoto H, Yokoyama H, Suzuki Y, Tsuzuki A, Takahashi K, Miya A, Kameda H, Cho KY, Takeuchi J, Nagai S, Taneda S, Kurihara Y, Nakamura A, Atsumi T (2023)
Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study)
Diabetes Obes Metab
:
Furusawa S, Nomoto H, Yokoyama H, Suzuki Y, Tsuzuki A, Takahashi K, Miya A, Kameda H, Cho KY, Takeuchi J, Nagai S, Taneda S, Kurihara Y, Nakamura A, Atsumi T (2023)
Diabetes Obes Metab
: